Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial
AbbVie
Désirée van der Heijde; In-Ho Song; Aileen L Pangan; Atul Deodhar; Filip van den Bosch; Walter P Maksymowych; Tae-Hwan Kim; Mitsumasa Kishimoto; Andrea Everding; Yunxia Sui; Xin Wang; Alvina D Chu; Joachim Sieper
Immunology Clinical Development and Data and Statistical Sciences, AbbVie, North Chicago, IL, USA. ; Immunology Clinical Development and Data and Statistical Sciences, AbbVie, North Chicago, IL, USA.